Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00102414
Recruitment Status : Completed
First Posted : January 31, 2005
Last Update Posted : November 14, 2006
Information provided by:
AGO Study Group